HCA UK at UCH is a joint partnership between HCA Healthcare UK and University College London Hospital.

Our multidisciplinary team of leading consultants and clinical nurse specialists treat, guide and support our patients from diagnostic tests, through to treatment and follow up care.

The conditions we treat

We work with expert consultant haematologists and oncologists to treat cancer and blood disorders, solid cancer tumours and blood disorders. Our team of leading neurologists and haematologists provide the complete Haematopoietic Stem Cell Transplant (HSCT) pathway, for patients with multiple sclerosis (MS). 

Together we provide an outstanding level of personalised medicine, from diagnostic assessment through to treatment and supportive care. All of our services are delivered in specialist environments by a world-class team, with uncompromising patient safety standards.

Blood cancer

At HCA UK at University College Hospital we offer specialist care for blood cancers. Our team of specialist haemato-oncologists provide expert treatment for leukaemia, myeloma and lymphoma.

We provide comprehensive care from diagnostic assessment to treatment and supportive care.  We can treat all blood cancers and have been awarded JACIE accreditation for our bone marrow and stem cell transplant service.  Our experienced team are here to guide and support you through your treatment. 

We are now offering, CAR T-cell therapy, a revolutionary treatment that uses a patient's own immune system to target certain types of blood cancer.

Autoimmune disorders

Our team of leading neurologists and haematologists work together in multidisciplinary teams to provide the complete Haematopoietic Stem Cell Transplant (HSCT) pathway, for patients with multiple sclerosis (MS).

Our expertise

Our experienced consultant-led teams provide specialist care, so you can be assured that you are in expert hands. We are continually investing in our facilities and technology to ensure you have access to the latest treatments available, including advanced radiotherapy and immunotherapy. 
 
We work with clinical investigators to develop new and innovative cancer therapies through our clinical trials facility - the Sarah Cannon Research Institute UK. We are the only private provider in the UK to operate a dedicated clinical trials facility; meaning you could have direct access to the latest cancer therapies and emerging treatments sooner.

Our commitment to safe and effective care is consistently reflected in our quality outcomes, highlighted in our 'Outstanding' rating from the Care Quality Commission, and our status as a JACIE accredited bone marrow and stem cell transplant centre.
Information for patients at UCH

Patient information

Find out more details about coming into hospital, supportive care and paying for your treatment. We are with you every step of the way. 

Information for patients
Our specialist teams

Our specialist teams

Our consultant-led teams provide specialist care for our patients during diagnosis, treatment and follow up care.

More about our expert teams
Talk to us

Comments and Complaints

Whether you're a patient, relative or visitor to HCA UK at University College Hospital, we want to make sure your experience is a positive one. We welcome your feedback so that we can continue to improve our services.

Our process
ISO logo

Accreditation

At HCA UK at University College Hospital, we operate a Quality Management System which complies with the requirements of ISO 9001:2015 for Oncology, Systemic Anti-Cancer Therapies (SACT) and Radiotherapy Services which include the use of CT scanners, Linear Accelerators (Linacs).

back to top